Skip to main content
. 2014 Mar 4;2014:930803. doi: 10.1155/2014/930803

Figure 5.

Figure 5

Difference in rate of blood loss from lesions treated with Hemopatch and those treated with TachoSil obtained from the linear mixed effects model, where the bleeding rate of TachoSil is subtracted from that of Hemopatch. Hemopatch had a statistically significant, at the 5% level, less bleeding rate over time as the upper 95% confidence limit is less than zero.